Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab Concurrent vs Sequential with Anthracyclines in Breast Cancer
NCT01413828Phase 3Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2011
- Primary completion
- Aug 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of trastuzumab in breast cancer, sponsored by Peking Union Medical College Hospital. Started May 2011; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01413828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01413828.